
Precipio PRPO
€ 20.20
1.39%
Quartalsbericht 2026-Q1
hinzugefügt 14.05.2026
Precipio ROE 2011-2026 | PRPO
ROE Jährlich Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.49 | -35.47 | -40.56 | -74.7 | -34.67 | -75.17 | -100.29 | -256.31 | -158.88 | 39.36 | 257.05 | -212.76 | - | - | - | -36.87 | -16.46 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 257.05 | -256.31 | -53.45 |
ROE Vierteljährlich Precipio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.71 | -12.77 | -22.27 | -39.14 | -31.59 | -42.78 | -53.81 | -65.04 | -48.76 | -66.15 | -65.35 | -69.68 | -48.38 | -55.53 | -49.19 | -48.78 | -28.18 | -51.47 | -60.11 | -71.74 | -61.75 | -76.12 | -97.61 | -94.33 | -71.65 | -134.52 | -166.39 | -161.44 | -148.93 | -197.15 | -162.54 | -122.12 | -82.29 | -74.56 | -19.48 | 25.65 | 31.47 | 88.4 | 106.22 | 123.07 | 106.2 | 17.8 | -40.36 | -278.66 | -515.14 | -461.53 | -599.98 | -526.89 | -453.81 | -430.43 | -331.83 | -194.94 | -68.56 | -54.76 | -25.18 | -76.69 | -88.54 | -11.5 | -54.29 | -25.14 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 123.07 | -599.98 | -105.98 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
-176.06 | $ 92.59 | 5.9 % | $ 4.33 B | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 4.5 | -10.89 % | $ 5.99 M | ||
|
Fulgent Genetics
FLGT
|
-5.44 | $ 18.5 | 1.04 % | $ 569 M | ||
|
Castle Biosciences
CSTL
|
-5.13 | $ 21.08 | 4.77 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
2.49 | $ 151.82 | -0.28 % | $ 11.9 B | ||
|
Illumina
ILMN
|
31.22 | $ 160.03 | 1.26 % | $ 24.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
419.21 | $ 130.12 | 4.19 % | $ 16.3 B | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 22.75 | 3.64 % | $ 1.21 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
-12.91 | $ 11.44 | 4.47 % | $ 1.47 B | ||
|
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
82.92 | $ 19.75 | 2.17 % | $ 442 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 99.98 | -0.03 % | $ 6.75 B | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 189.85 | 1.83 % | $ 9.41 B | ||
|
Pacific Biosciences of California
PACB
|
-10214.99 | $ 1.37 | -0.72 % | $ 411 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 466.79 | 1.94 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 162.79 | 2.1 % | $ 24 B | ||
|
Myriad Genetics
MYGN
|
-99.46 | $ 4.54 | 3.42 % | $ 420 M | ||
|
Natera
NTRA
|
-12.16 | $ 222.82 | 4.38 % | $ 30.5 B | ||
|
Personalis
PSNL
|
-31.12 | $ 9.75 | -2.89 % | $ 870 M | ||
|
Koninklijke Philips N.V.
PHG
|
8.16 | $ 26.5 | 2.63 % | $ 25.1 B | ||
|
Senseonics Holdings
SENS
|
-113.19 | $ 7.43 | 4.21 % | $ 310 M | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.05 | -0.92 % | $ 4.71 M | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 271.24 | 3.52 % | $ 22.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-16.42 | $ 70.06 | 0.03 % | $ 4.19 B | ||
|
Thermo Fisher Scientific
TMO
|
12.55 | $ 494.07 | 5.23 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
88.73 | $ 0.66 | -2.32 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.29 | 2.43 % | $ 2.01 B | ||
|
Waters Corporation
WAT
|
25.09 | $ 371.15 | 2.15 % | $ 22.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 204.53 | 3.71 % | $ 22.7 B |